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258a Monday, March 7, 2011(10-5M), inhibitors of PI3K, largely reduced UcnII-induced phosphorylation of
Akt and eNOS, respectively (n=11-20, P<0.05). Cellular NO production in-
creased by 41.155.5% (n=20, P<0.01), which was inhibited by eNOS inhib-
itors, L-NIO (10-5M) and L-NAME (1mM) by ~30% (n=4-8, P<0.05).
Inhibition of PKA by H89 (5x10-6M) also reduced eNOS phosphorylation
(n=11, P<0.05) but did not affect Akt phosphorylation. Direct stimulation of
cAMP/PKA signaling via forskolin (10-5M) increased phosphorylation of
eNOS (n=5, P<0.05) but not of Akt. When both PI3K/Akt (LY294002 10-
5M) and cAMP/PKA (H89 10-6M) signaling were inhibited, the UcnII-
induced increase of [NO]i was attenuated by ~20% (n=10, P<0.01). UcnII
also increased [NO]i in mouse, rat, and human ventricular myocytes as well
as in rabbit atrial myocytes (n=4-12).
SUMMARY: We conclude that, in cardiac myocytes, UcnII causes eNOS
phosphorylation to stimulate cellular NO production via both cAMP/PKA
and PI3K/Akt signaling.
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Deficient Regulation of Gbetagamma Effectors by Fluorescently Labeled
Galpha i3 Subunits Reveals Distinct Aspects of Coupling to GIRK and
Cav2.2 Channels
Shai Berlin, Vladimir Tsemakhovich, Carmen W. Dessauer, Nathan Dascal.
It has been proposed that Gai subunits regulate, and form signaling complexes
with, effectors primarily regulated by Gbg, notably G protein activated Kþ
channel (GIRK) and N-type Ca2þ channel CaV2.2. To investigate Gai signal-
ing mechanisms, we tested three Gai3 derivatives tagged by YFP and CFP
(Gai3xFP). Gai3NT carried a myristoylation signal followed by xFP, preced-
ing the Ga protein, similar to other GaixFPs reported as fully functional [An
internally labeled Gai3117 was previously used to study Ga-Gbg interactions
[Gibson SK & Gilman AG, PNAS 103: 212]. In a novel Gai3CT, xFP was
fused C-terminally to Gai3. All Gai3xFPs and wt-Gai3 bound Gbg and
GIRK1. However, Gbg did not enhance the Gai3xFP-GIRK1 interaction, as
observed for wt-Gai3. Only Gai3117 and Gai3CT, but not Gai3NT, controlled
GIRK’s basal activity. Muscarinic 2 receptor (m2R) activated the GIRK chan-
nel via pertussis toxin-insensitive wt-Gai3, Gai3117 and Gai3NT, but not
Gai3CT. However, only Gai3NT produced fast activation kinetics comparable
to wt-Gai3, whereas Gai3117 greatly slowed the activation kinetics. As ex-
pected, activation of m2R inhibited CaV2.2 in a voltage-dependent manner
but only via wt-Gai3 and Gai3NT, and not via Gai3117 or Gai3CT. xFP-
Gbg, but none of the xFP-labeled Ga subunits, showed FRET with xFP-
GIRK1. Our results suggest that xFP labeling of Ga, even at positions widely
regarded as producing functional Ga proteins, distort some or all of Ga-effec-
tor interactions and regulations. Incidentally, the differential regulation of
basal and evoked GIRK activity by Gai3NT and Gai3117 reveal that control
of GIRK’s basal activity and the provision of "free" Gbg for GIRK activation
(following GPCR activation) are distinct functions of the Ga subunit. Neither
mechanism is a prerequisite for the other. Supported by ISF (ND) and BSF
(CWD, ND).
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GPCR Ligands Differentially Modulate Islet Metabolism and Ca2þ Signal-
ing
Tara A. Schwetz, David W. Piston.
Glucose homeostasis is a tightly regulated process coordinated by insulin and
glucagon secretion. In a- and b-cells, G-protein coupled receptor (GPCR) ac-
tivation facilitates the optimization of insulin and glucagon secretion.
Glucagon-like peptide-1 (GLP-1), a ligand activating the Gs pathway, in-
creases insulin secretion, but inhibits glucagon secretion. Neuropeptide-Y
(NPY) and somatostatin (SST), whose receptors are coupled to Gi, inhibit in-
sulin secretion; however, NPY stimulates glucagon release, while SST inhibits
glucagon secretion. Here, we question whether and how these GPCR ligands
impact cellular metabolism and oscillations of intracellular Ca2þ activity
([Ca2þ]i) to alter secretion in the pancreatic islet. We utilized two-photon ex-
citation microscopy to measure the combined autofluorescence of NADH and
NADPH (NAD(P)H, a cellular redox state indicator) upon application of
NPY, SST, or GLP-1. Under untreated conditions, an increase in extracellular
glucose results in elevated NAD(P)H fluorescence intensities. Treatment with
NPY and SST produces a supplementary increase in NAD(P)H autofluores-
cence at glucose concentrations above 5 mM compared to untreated control.
NAD(P)H autofluorescence is not impacted significantly (relative to untreated
control) by GLP-1 treatment, which is consistent with a previous report that
found that GLP-1 does not alter b-cell metabolism. At glucose concentrations
greater than ~7 mM, pancreatic islets display synchronous oscillations in
[Ca2þ]i, leading to the pulsatile release of insulin. The [Ca
2þ]i oscillation fre-
quency increases significantly in the presence of NPY. SST treatment de-
creases the oscillation frequency in b-cells, but does not affect a-cells.Addition of GLP-1 does not significantly alter the [Ca2þ]i oscillation fre-
quency. Thus, GLP-1 likely modulates insulin and glucagon secretion down-
stream of Ca2þ signaling. NPY may inhibit insulin secretion downstream of
Ca2þ signaling, but stimulates glucagon secretion upstream of Ca2þ activity.
Islet hormone secretion may be inhibited by SST through alteration of path-
ways up- and downstream of Ca2þ signaling.
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An Ampa Receptor Unique Asp-Lys Salt-Bridge has a Role in Channel
Function
Sandra M. Holley, Jayasri Srinivasan, Ahmed H. Ahmed, Robert E. Oswald,
Linda M. Nowak.
Several of the many steps in the mechanism of activation of tetrameric GluA
receptor-channels have been explored in a variety of published structural and
functional studies. The main findings from them are that 1) Agonist binding in-
duces closure of the L1/L2 of the isolated ligand-binding domain (LBD) that is
less for partial agonists than for glutamate. 2) Crystal structures of GluA LBDs
bound to full agonists manifest a 180o rotation around an Asp-Ser transpeptide
bond in a flexible part of L2 that leads to the formation of cross-interface
H-bonds also hypothesized to play a role in receptor activation. 3) Channel con-
ductance increases with increasing agonist concentration, consistent with mul-
tiple LBDs in the tetramer contributing to full channel activation. Here we
show that the Asp of the Asp-Ser pair also makes an electrostatic contact
with a Lys residue in helix-F, and that disrupting this salt-bridge in GluA3flip
receptors with point mutations at D655 and K660 decreased agonist potency by
2-10 fold. In D655A where it was examined, this occurred without altering in-
trinsic receptor affinity for agonists in ligand binding assays or CNQX by
Schild analysis. The D655A mutation also increased the efficacy of kainate rel-
ative to glutamate, and the isolated GluA-D655A LDB bound to kainate was 3
more closed than in wildtype. Pharmacological studies of the wildtype and mu-
tant receptors expressed in human embryonic kidney cells employed whole cell
patch recordings and structure data was from crystals of isolated wildtype and
mutant LBDs bound to full agonists and kainate. Taken together, these studies
showed that breaking the D655-K660 contact altered channel gating, indicating
that tethering a flexible part of L2 to helix-F may contribute to the rapid acti-
vation of GluA receptors.
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The Role of P2X4 Receptors in Calcium-Mediated Exocytosis in Parotid
Acinar Cells
Sumit Bhattacharya, Douglas Verrill, David Giovannucci.
Saliva is largely generated as a result of both parasympathetic and sympathetic
neural input to the parotid salivary gland. Muscarinic and adrenergic receptor
activations are the dominant signals that regulate fluid and protein secretion
during salivation. In addition to these pathways, recent studies have suggested
a noncholinergic, nonadrenergic pathway that contributes to salivation. One
candidate for this pathway is the P2X class of Ca2þ permeable ion channels
that evoke Ca2þ signals in response to extracellular adenosine triphosphate
(ATP). P2X4 and P2X7 are the only two purinergic ionotropic receptors iden-
tified in the mouse parotid acinar cells. P2X7 receptors have been shown to be
an important regulator of fluid secretion in the salivary gland. However, the
physiological role of P2X4 receptors in parotid acinar cells remains ill defined.
In this study, multi-photon and live-cell imaging of acinar clumps and organo-
typic slices were used to quantify changes in intracellular Ca2þ and monitor se-
cretory events. We now demonstrate that activation of P2X4 purinergic
receptors in mouse parotid acinar cells by extracellular ATP evoked Ca2þ in-
flux and protein secretion in a concentration-dependent manner. Pre-
treatment with ivermectin (a specific positive allosteric modulator for P2X4),
induced a 3-fold leftward shift in the EC50 of the Ca
2þ peak amplitude induced
by ATP. Moreover, there was 8-fold enhancement in the number of Ca2þ-
evoked secretory events. These data identify P2X4 receptors as a novel regula-
tor of fluid and protein secretion in the parotid gland and have implications for
treatment of salivary hypofunction diseases like Sjo¨gren’s syndrome.
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Isoform-Specific Translocation of PKC in HEK293T Cells by Alpha1-
Adrenergic Stimulation
Jaime Sorenson, Jin Ouchi, Kaleef Williams, Coeli Lopes.
Protein kinase C (PKC), a multi-gene family of enzymes, plays key roles in the
regulation of signal transduction and cellular function in various cell types. In-
tracellular localization and trafficking of these individual PKC isoforms are im-
portant for regulation of enzyme activity and substrate specificity. PKC can be
activated at downstream of Gq-protein coupled receptor (GqPCR) signaling
and recent reports suggested that different type of GqPCRs would activate dif-
ferent isoforms of PKC (classic, novel and atypical PKCs). However, the
